BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25518400)

  • 21. Kawasaki Disease: The Role of Immune Complexes Revisited.
    Menikou S; Langford PR; Levin M
    Front Immunol; 2019; 10():1156. PubMed ID: 31263461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
    Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M
    Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological and ultrastructural examinations of rabbit coronary artery vasculitis caused by bovine serum albumin: an animal model of Kawasaki disease.
    Dou J; Li H; Sun L; Yan W; Lv H; Ding Y
    Ultrastruct Pathol; 2013 Apr; 37(2):139-45. PubMed ID: 23573894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of auto-antibodies against a 70 kDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease.
    Suzuki H; Muragaki Y; Uemura S; Takeuchi T; Minami T; Shibuta S; Ohshima A; Yoshikawa N
    Eur J Pediatr; 2002 Jun; 161(6):324-9. PubMed ID: 12029451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease.
    Leung DY
    Acta Paediatr Jpn; 1991 Dec; 33(6):739-44. PubMed ID: 1801553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cyclosporin A treatment for refractory Kawasaki disease].
    Suzuki H; Suenaga T; Kakimoto N; Takeuchi T; Shibuta S
    Nihon Rinsho; 2014 Sep; 72(9):1636-40. PubMed ID: 25518415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
    Lau AC; Duong TT; Ito S; Yeung RS
    Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.
    Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ
    Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The up-to-date pathophysiology of Kawasaki disease.
    Hara T; Yamamura K; Sakai Y
    Clin Transl Immunology; 2021; 10(5):e1284. PubMed ID: 33981434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathology of Kawasaki disease].
    Shirai N; Yabana T; Ueda M
    Nihon Rinsho; 2008 Feb; 66(2):251-7. PubMed ID: 18260322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease.
    Scardina GA; FucĂ  G; Carini F; Valenza V; Spicola M; Procaccianti P; Messina P; Maresi E
    Med Oral Patol Oral Cir Bucal; 2007 Dec; 12(8):E560-4. PubMed ID: 18059239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.
    Matsubara T; Ichiyama T; Furukawa S
    Clin Exp Immunol; 2005 Sep; 141(3):381-7. PubMed ID: 16045726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kawasaki Disease Following Severe Sunburn Injury.
    Okada S; Hashimoto S; Miyake A; Okada Y; Hirano R; Fukunaga S; Ishikawa Y
    Front Pediatr; 2020; 8():6. PubMed ID: 32047731
    [No Abstract]   [Full Text] [Related]  

  • 34. Recognition of bacterial infection by innate immune sensors.
    Kumar S; Ingle H; Prasad DV; Kumar H
    Crit Rev Microbiol; 2013 Aug; 39(3):229-46. PubMed ID: 22866947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological evaluation of horse serum-induced immune complex vasculitis in swine: implication to coronary artery lesions in Kawasaki disease.
    Philip S; Lee WC; Wu MH; Mammen CK; Lue HC
    Pediatr Neonatol; 2014 Aug; 55(4):297-305. PubMed ID: 24491664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Should We Classify Kawasaki Disease?
    Marrani E; Burns JC; Cimaz R
    Front Immunol; 2018; 9():2974. PubMed ID: 30619331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF and IL-1 Play Essential but Temporally Distinct Roles in Driving Cardiac Inflammation in a Murine Model of Kawasaki Disease.
    Stock AT; Jama HA; Hansen JA; Wicks IP
    J Immunol; 2019 Jun; 202(11):3151-3160. PubMed ID: 30996002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins.
    Breunis WB; Davila S; Shimizu C; Oharaseki T; Takahashi K; van Houdt M; Khor CC; Wright VJ; Levin M; Burns JC; Burgner D; Hibberd ML; Kuijpers TW;
    Arthritis Rheum; 2012 Jan; 64(1):306-15. PubMed ID: 21905000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.